KIR3DS1 directs NK cell–mediated protection against human adenovirus infections
Johannes M. Jung, Wilhelm Ching, Martin E. Baumdick, Helga Hofmann-Sieber, Jens B. Bosse, Tobias Koyro, Kimberly J. Möller, Lucy H.M. Wegner, Annika Niehrs, Kristina Russu, Mareike Ohms, Wenli Zhang, Anja Ehrhardt, Kevin Duisters, Eric Spierings, Angelique Hölzemer, Christian Körner, Suze A. Jansen, Sven Peine, Ingo Königs, Marc Lütgehetmann, Daniel Pérez, Konrad Reinshagen, Caroline A. Lindemans, Marcus Altfeld, Mirjam E. Belderbos, Thomas Dobner, Madeleine J. Bunders
Abstract
cells. These findings identify the KIR3DS1/HLA-F axis as a new target for immunotherapeutic strategies against severe HAdV disease.
Topics & Concepts
ImmunologyBiologyImmune systemViremiaTransplantationMedicineVirusSurgeryImmune Cell Function and InteractionVirus-based gene therapy researchHematopoietic Stem Cell Transplantation